Fig. 3From: Additive antiangiogenesis effect of ginsenoside Rg3 with low-dose metronomic temozolomide on rat glioma cells both in vivo and in vitroTMZ and RG3 additively inhibited rat C6 glioma cell proliferation. Cells were seeded in 24 well plates and treated with TMZ and/or RG3 for designated time and doses. a TMZ inhibited C6 glioma cell proliferation in a time and dose dependent manner. b RG3 inhibited C6 glioma cell proliferation in a time and dose dependent way. c TMZ and RG3 additively inhibited proliferation of C6 glioma cells. Bars with different letters indicate significant difference (P < 0.05) based on post-hoc Tukey analysisBack to article page